SCHEMBL3668413

SCHEMBL3668413

COc1ccc(-c2c(-c3ccccc3)oc(C)c2OC(=O)O)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.46
KDM4E B2RXH2 5/20 0.46
HPGD P15428 5/20 0.46
MAPT P10636 4/20 0.46
SMN1; SMN2 Q16637 3/20 0.46
NPC1 O15118 3/20 0.46
RAB9A P51151 3/20 0.46
LMNA P02545 2/20 0.46
CYP1A2 P05177 2/20 0.46
CYP2C9 P11712 2/20 0.46
CYP2C19 P33261 2/20 0.46
MEN1 O00255 1/20 0.46
GAA P10253 1/20 0.46
HTT P42858 1/20 0.46
KMT2A Q03164 1/20 0.46
NPSR1 Q6W5P4 1/20 0.46
L3MBTL1 Q9Y468 3/20 0.45
UBE2N P61088 1/20 0.44
BACE1 P56817 2/20 0.44
POLB P06746 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3666194 0.90 MAPT (0.47) ALDH1A1KDM4EHPGDMAPTSMN1; SMN2
SCHEMBL3668412 0.81 ALDH1A1 (0.55) ALDH1A1KDM4EHPGDMAPTSMN1; SMN2
SCHEMBL6517154 0.79 L3MBTL1 (0.57) ALDH1A1KDM4EHPGDMAPTSMN1; SMN2
SCHEMBL3660725 0.76 ESR1 (0.52) ALDH1A1KDM4EHPGDMAPTSMN1; SMN2
SCHEMBL3666080 0.76 ALDH1A1 (0.46) ALDH1A1KDM4EHPGDMAPTSMN1; SMN2
SCHEMBL13087217 0.71 KDM4E (0.55) ALDH1A1KDM4EHPGDMAPTSMN1; SMN2
Bicarbonate SCHEMBL28112150 0.69 CES2 (0.61) ALDH1A1KDM4ENPC1RAB9ALMNA
SCHEMBL21667786 0.69 CA4 (0.62) ALDH1A1KDM4ENPC1RAB9ALMNA
SCHEMBL15189750 0.69 ALDH1A1 (0.43) ALDH1A1KDM4EHPGDMAPTNPC1
SCHEMBL6223461 0.68 ESR2 (0.56) ALDH1A1SMN1; SMN2NPC1RAB9ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2240461-A1 SUBSTITUTED FURANS AND USE THEREOF Bayer Schering Pharma Aktiengesellschaft (DE) 2010-10-20 EP disclosed
WO-2009097991-A1 SUBSTITUTED FURANS AND USE THEREOF BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2009-08-13 WO disclosed